Silvant Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-15,237
| Closed | -$1.74M | – | 339 |
|
|
2020
Q3 | $1.74M | Sell |
15,237
-4,095
| -21% | -$469K | 0.33% | 78 |
|
|
2020
Q2 | $2.17M | Sell |
19,332
-1,298
| -6% | -$146K | 0.39% | 72 |
|
|
2020
Q1 | $1.85M | Sell |
20,630
-404
| -2% | -$36.3K | 0.4% | 70 |
|
|
2019
Q4 | $2.27M | Sell |
21,034
-323
| -2% | -$34.9K | 0.41% | 72 |
|
|
2019
Q3 | $2.09M | Sell |
21,357
-2,716
| -11% | -$266K | 0.41% | 68 |
|
|
2019
Q2 | $3.15M | Sell |
24,073
-2,251
| -9% | -$295K | 0.56% | 54 |
|
|
2019
Q1 | $3.56M | Sell |
26,324
-1,078
| -4% | -$146K | 0.64% | 48 |
|
|
2018
Q4 | $2.67M | Sell |
27,402
-795
| -3% | -$77.4K | 0.53% | 59 |
|
|
2018
Q3 | $3.92M | Sell |
28,197
-4,481
| -14% | -$623K | 0.48% | 76 |
|
|
2018
Q2 | $4.06M | Sell |
32,678
-376
| -1% | -$46.7K | 0.5% | 75 |
|
|
2018
Q1 | $3.68M | Buy |
+33,054
| New | +$3.68M | 0.47% | 78 |
|